{"id":540,"date":"2021-11-25T19:15:21","date_gmt":"2021-11-25T19:15:21","guid":{"rendered":"https:\/\/www.innaxon.cz\/?page_id=540"},"modified":"2021-11-25T19:41:57","modified_gmt":"2021-11-25T19:41:57","slug":"literature","status":"publish","type":"page","link":"https:\/\/www.innaxon.cz\/index.php\/literature\/","title":{"rendered":"Literature"},"content":{"rendered":"\n

\n\t\tLiterature\n\t<\/h1>\n\t

Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators<\/strong><\/a><\/h2>\n

Alessio Romerio<\/a>,\u00a0Francesco Peri<\/a>, Front Immunol. (2020), 11:1210<\/p>\n

Toll-Like Receptor 4 (TLR4) is one of the receptors of innate immunity. It is activated by Pathogen- and Damage-Associated Molecular Patterns (PAMPs and DAMPs) and triggers pro-inflammatory responses that belong to the repertoire of innate immune responses, consequently protecting against infectious challenges and boosting adaptive immunity. Mild TLR4 stimulation by non-toxic molecules resembling its natural agonist (lipid A) provided efficient vaccine adjuvants.<\/p>\n

Read article ><\/strong><\/a><\/p>\n\t

Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance<\/strong><\/a><\/h2>\n

J Neural Eng.<\/a> 15:025002 (2018). Hermann JK<\/a>1<\/sup>,\u00a0Ravikumar M<\/a>,\u00a0Shoffstall AJ<\/a>,\u00a0Ereifej ES<\/a>,\u00a0Kovach KM<\/a>,\u00a0Chang J<\/a>,\u00a0Soffer A<\/a>,\u00a0Wong C<\/a>,\u00a0Srivastava V<\/a>,\u00a0Smith P<\/a>,\u00a0Protasiewicz G<\/a>,\u00a0Jiang J<\/a>,\u00a0Selkirk SM<\/a>,\u00a0Miller RH<\/a>,\u00a0Sidik S<\/a>,\u00a0Ziats NP<\/a>,\u00a0Taylor DM<\/a>,\u00a0Capadona JR<\/a>.<\/p>\n

Neuroinflammatory mechanisms are hypothesized to contribute to intracortical microelectrode failures. The cluster of differentiation 14 (CD14) molecule is an innate immunity receptor involved in the recognition of pathogens and tissue damage to promote inflammation. The goal of the study was to investigate the effect of CD14 inhibition on intracortical microelectrode recording performance and tissue integration.<\/p>\n

Read article ><\/strong><\/a><\/p>\n\t

TLR4-Mediated Placental Pathology and Pregnancy Outcome in Experimental Malaria\u00a0<\/strong><\/a><\/h2>\n

Sci Rep.<\/a> 7:8623 (2017). Barboza R<\/a>1<\/sup>,\u00a0Lima FA<\/a>2<\/sup>,\u00a0Reis AS<\/a>2<\/sup>,\u00a0Murillo OJ<\/a>2<\/sup>,\u00a0Peixoto EPM<\/a>2<\/sup>,\u00a0Bandeira CL<\/a>2<\/sup>,\u00a0Fotoran WL<\/a>2<\/sup>,\u00a0Sardinha LR<\/a>3<\/sup>,\u00a0Wunderlich G<\/a>2<\/sup>,\u00a0Bevilacqua E<\/a>4<\/sup>,\u00a0Lima MRD<\/a>5<\/sup>,\u00a0Alvarez JM<\/a>5<\/sup>,\u00a0Costa FTM<\/a>6<\/sup>,\u00a0Gon\u00e7alves LA<\/a>2<\/sup>,\u00a0Epiphanio S<\/a>7<\/sup>,\u00a0Marinho CRF<\/a>8<\/sup>.<\/p>\n

Malaria-associated pregnancy has a significant impact on infant morbidity and mortality. The detrimental effects of malaria infection during pregnancy have been shown to correlate with immune activation in the placental tissue. Herein we sought to evaluate the effect of Toll-like receptors (TLRs) activation on placental malaria (PM) development by using the Plasmodium berghei NK65GFP<\/sup>\u00a0infection model. We observed that activation of the innate immune system by parasites leads to PM due to local inflammation.<\/p>\n

Read article ><\/strong><\/a><\/p>\n\t

Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental\u00a0Subarachnoid Hemorrhage in Mice\u00a0<\/strong><\/a><\/h2>\n

Mol Neurobiol.<\/a>\u00a054:6624-6633 (2017).\u00a0Kawakita F<\/a>1<\/sup>,\u00a0Fujimoto M<\/a>1<\/sup>,\u00a0Liu L<\/a>1<\/sup>,\u00a0Nakano F<\/a>1<\/sup>,\u00a0Nakatsuka Y<\/a>1<\/sup>,\u00a0Suzuki H<\/a>2<\/sup>.<\/p>\n

Toll-like receptor 4 (TLR4) signaling may play a crucial role in the occurrence of cerebral vasospasm after subarachnoid hemorrhage (SAH). The main purpose of this study was to assess if selective blockage of TLR4 on cerebral arteries prevents cerebral vasospasm development and neurological impairments after SAH in mice.<\/p>\n

Read article ><\/strong><\/a><\/p>\n\t

Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model (2016)<\/b><\/a><\/h2>\n

Pharmacol Res. 103:180 (2016). De Paola M1, Sestito SE2, Mariani A3, Memo C3, Fanelli R3, Freschi M4, Bendotti C4, Calabrese V2, Peri F5.<\/p>\n

Increasing evidence indicates that inflammatory responses could play a critical role in the pathogenesis of motor neuron injury in amyotrophic lateral sclerosis (ALS). Recent findings have underlined the role of Toll-like receptors (TLRs) and the involvement of both the innate and adaptive immune responses in ALS pathogenesis.<\/p>\n

Read article ><\/strong><\/a><\/p>\n

A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development<\/strong>\u00a0(2015)<\/strong><\/a><\/h2>\n
\n\n

Atherosclerosis. 242:563 (2015). Huggins C1, Pearce S1, Peri F2, Neumann F3, Cockerill G1, Pirianov G4.<\/p>\n

The toll-like receptors (TLRs), including TLR4, have been shown to play a crucial role in vascular inflammatory diseases, such as atherosclerosis and aneurysm. The main goal of this study was to determine the potential of IAXO-102 (Innaxon, Tewkesbury), a novel small molecule TLR4 antagonist, to modulate non-hematopoietic TLR4 proinflammatory signalling and inhibit experimental abdominal aortic aneurysm (AAA) development.<\/p>\n

Read article ><\/strong><\/a><\/p>\n<\/article>\n

Toll like Receptor 4 antagonist prevents acetaminophen induced acute liver failure in mice: A novel therapeutic strategy (2012)<\/strong><\/a><\/h2>\n
\n

Shah, D. Dhar, M. Jover, N.A. Davies, R.P. Mookerjee, R. Jalan UCL, Institute of Hepatology, London, UK<\/p>\n

Without transplantation, about 40% of patients with acute liver failure (ALF) die. Its treatment is an unmet need. Unregulated inflammation plays an important role in the pathogenesis. Our hypothesis is that Toll like receptor 4 (TLR 4) is critical in the progression of inflammation in ALF. The aims of the study were to determine whether 1) administration of a novel TLR4 antagonist to an APAP model of ALF in mice would prevent liver injury. 2) TLR4 antagonist in ALF prolongs survival. 3) TLR4 KO are protected from the liver injury induced by acetaminophen (APAP).<\/p>\n

Read article ><\/strong><\/a><\/p>\n<\/article>\n\n","protected":false},"excerpt":{"rendered":"

Literature Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators Alessio Romerio,\u00a0Francesco Peri, Front Immunol. (2020), 11:1210 Toll-Like Receptor 4 (TLR4) is one of the receptors of innate immunity. It is activated by Pathogen- and Damage-Associated Molecular Patterns (PAMPs and DAMPs) and triggers pro-inflammatory responses that belong to the repertoire of<\/p>\n

Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-540","page","type-page","status-publish","hentry"],"yoast_head":"\nLiterature - Innaxon, s.r.o.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.innaxon.cz\/index.php\/literature\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Literature - Innaxon, s.r.o.\" \/>\n<meta property=\"og:description\" content=\"Literature Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators Alessio Romerio,\u00a0Francesco Peri, Front Immunol. (2020), 11:1210 Toll-Like Receptor 4 (TLR4) is one of the receptors of innate immunity. It is activated by Pathogen- and Damage-Associated Molecular Patterns (PAMPs and DAMPs) and triggers pro-inflammatory responses that belong to the repertoire ofRead More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.innaxon.cz\/index.php\/literature\/\" \/>\n<meta property=\"og:site_name\" content=\"Innaxon, s.r.o.\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-25T19:41:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.innaxon.cz\/index.php\/literature\/\",\"url\":\"https:\/\/www.innaxon.cz\/index.php\/literature\/\",\"name\":\"Literature - Innaxon, s.r.o.\",\"isPartOf\":{\"@id\":\"https:\/\/www.innaxon.cz\/#website\"},\"datePublished\":\"2021-11-25T19:15:21+00:00\",\"dateModified\":\"2021-11-25T19:41:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.innaxon.cz\/index.php\/literature\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.innaxon.cz\/index.php\/literature\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.innaxon.cz\/index.php\/literature\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.innaxon.cz\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Literature\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.innaxon.cz\/#website\",\"url\":\"https:\/\/www.innaxon.cz\/\",\"name\":\"Innaxon, s.r.o.\",\"description\":\"Targeting Innate Immunity For Therapeutic Benefit\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.innaxon.cz\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Literature - Innaxon, s.r.o.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.innaxon.cz\/index.php\/literature\/","og_locale":"en_GB","og_type":"article","og_title":"Literature - Innaxon, s.r.o.","og_description":"Literature Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators Alessio Romerio,\u00a0Francesco Peri, Front Immunol. (2020), 11:1210 Toll-Like Receptor 4 (TLR4) is one of the receptors of innate immunity. It is activated by Pathogen- and Damage-Associated Molecular Patterns (PAMPs and DAMPs) and triggers pro-inflammatory responses that belong to the repertoire ofRead More","og_url":"https:\/\/www.innaxon.cz\/index.php\/literature\/","og_site_name":"Innaxon, s.r.o.","article_modified_time":"2021-11-25T19:41:57+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.innaxon.cz\/index.php\/literature\/","url":"https:\/\/www.innaxon.cz\/index.php\/literature\/","name":"Literature - Innaxon, s.r.o.","isPartOf":{"@id":"https:\/\/www.innaxon.cz\/#website"},"datePublished":"2021-11-25T19:15:21+00:00","dateModified":"2021-11-25T19:41:57+00:00","breadcrumb":{"@id":"https:\/\/www.innaxon.cz\/index.php\/literature\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.innaxon.cz\/index.php\/literature\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.innaxon.cz\/index.php\/literature\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.innaxon.cz\/"},{"@type":"ListItem","position":2,"name":"Literature"}]},{"@type":"WebSite","@id":"https:\/\/www.innaxon.cz\/#website","url":"https:\/\/www.innaxon.cz\/","name":"Innaxon, s.r.o.","description":"Targeting Innate Immunity For Therapeutic Benefit","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.innaxon.cz\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/pages\/540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/comments?post=540"}],"version-history":[{"count":6,"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/pages\/540\/revisions"}],"predecessor-version":[{"id":577,"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/pages\/540\/revisions\/577"}],"wp:attachment":[{"href":"https:\/\/www.innaxon.cz\/index.php\/wp-json\/wp\/v2\/media?parent=540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}